(TVTX) – Hot Corp. News
-
Travere Therapeutics (TVTX) to Sell its Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases to Mirum (MIRM)
-
Travere Therapeutics (TVTX) Confirms FDA Accelerated Approval of FILSPARITM, the First and Only Non-immunosuppressive Therapy for the Reduction of Proteinuria in IgA Nephropathy
-
-
Back to TVTX Stock Lookup
